Items home
EnglishFrenchDutchSpanishGermanItalianChineseTurkishPolishUSA

EQA Programmes

A sample list of molecular EQA (PT) programmes available from QCMD is displayed below. Programmes specifically designed to US-CLIA specifications can be found under the ‘US-CLIA’ section.
For further information, to register or to access our catalogue please login to your QCMD Laboratory Profile. If you do not have a Username and Password please click here.

Click to view / hide
US-CLIA

Clostridium difficile

FeatureAvailable Formats
Catalogue NumberQAB084125_CMS
Total Number of Challenges3
Number of Panel Members5
Distribution / Testing PeriodQ2, Q3 & Q4

Chlamydia trachomatis and Neisseria gonorrhoeae

FeatureAvailable Formats
Catalogue NumberQAB174191_CMS
Total Number of Challenges3
Number of Panel Members5
Distribution / Testing PeriodQ2, Q3 & Q4

Influenza A & B virus

FeatureAvailable Formats
Catalogue NumberQAV054134_CMS
Total Number of Challenges3
Number of Panel Members5
Distribution / Testing PeriodQ2, Q3 & Q4
Click to view / hide
Blood Borne Virus

B19 virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034116_1QAV034116_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214221_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV-1 DNA EQA programme

FeatureAvailable Formats
Catalogue NumberQAV034114_1QAV034114_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Hepatitis A virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124156_1QAV124156_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Hepatitis B Virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994110_1QAV994110_2QAV994110_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Hepatitis B Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214223_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis B virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064118_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis C Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214222_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis C Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994112_1QAV994112_2QAV994112_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Hepatitis C virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034117_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis D Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144170_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

Hepatitis E virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124157_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

Human Immunodeficiency Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994108_1QAV994108_2QAV994108_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Human Immunodeficiency Virus Type 2 EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204212_1QAV204212_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3
Click to view / hide
Central Nervous System

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Borrelia burgdorferi spp. DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB114147_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV174195_1QAV174195_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174196_1QAM174196_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Chikungunya Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154175_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Dengue Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114148_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Enterovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV984104_1QAV984104_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Enterovirus Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164185_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Herpes simplex virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994105_1QAV994105_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Measles and Mumps EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144171_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Parechovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114145_1QAV114145_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Varicella-Zoster virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034103_1QAV034103_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

West Nile Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV104141_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Zika Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164186_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Congenital Infections

Cytomegalovirus Dried Blood Spot EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064127_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Drug Resistance

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Extended Spectrum β-lactamase and Carbapenemase EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134162_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Methicillin Resistant Staphylococcus aureus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB064124_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Mycobacterium Tuberculosis Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194209_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Vancomycin Resistant Enterococci EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134163_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3
Click to view / hide
Exotic / Emerging Diseases

Plasmodium spp. (Malaria) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214218_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Chikungunya Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154175_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Dengue Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114148_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Francisella tularensis EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAB214220_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

MERS Coronavirus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154181_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

SARS-CoV-2 EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV204215_1AQAV204215_1BQAV204215_1CQAV204215_1D
Total Number of Challenges1111
Number of Panel Members5555
Distribution / Testing PeriodQ1Q2Q3Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

West Nile Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV104141_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Yellow Fever Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV194207_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Zika Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164186_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Gastrointestinal Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Bacterial Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124153_1QAB124153_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Clostridium difficile DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB084125_1QAB084125_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Diarrheagenic Escherichia coli EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154179_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Helicobacter pylori EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164190_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Norovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084139_1QAV084139_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Parasitic Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP124154_1QAP124154_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Viral Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124152_1QAV124152_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Immunocompromised Associated Diseases

Aspergillus spp. DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF104140_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Candida spp. EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF124151_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Cytomegalovirus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124150_1QAV124150_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024121_1QAV024121_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134161_1QAV134161_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Cytomegalovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV014120_1QAV014120_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Herpes Virus 6 DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084119_1QAV084119_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF114144_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Torque Teno Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184203_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Multiple Pathogen/Syndromic

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Bacterial Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124153_1QAB124153_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV174195_1QAV174195_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174196_1QAM174196_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174191_1QAB174191_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

MALDI-TOF EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124155_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Parasitic Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP124154_1QAP124154_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Respiratory I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164188_1QAV164188_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164189_1QAV164189_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory III EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174193_1QAM174193_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Sepsis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164178_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Sexually Transmitted Infections I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154177_1QAB154177_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Sexually Transmitted Infections II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174201_1QAM174201_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Viral Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124152_1QAV124152_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Respiratory Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Atypical Mycobacterium EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194208_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Bordetella pertussis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB094132_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Chlamydia psittaci EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134165_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Chlamydophila pneumoniae EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB084107_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Coronavirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064137_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Influenza Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064138_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Influenza virus A and B RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054134_1QAV054134_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Legionella pneumophila DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB044122_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ1

MERS Coronavirus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154181_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Measles and Mumps EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144171_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Metapneumovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054135_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Mycobacterium Tuberculosis Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194209_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Mycobacterium tuberculosis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB014129_1QAB014129_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Mycoplasma pneumoniae EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174192_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Parainfluenza Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064136_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF114144_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164188_1QAV164188_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164189_1QAV164189_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory III EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174193_1QAM174193_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory Syncytial Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054142_1QAV054142_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Rhinovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064143_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

SARS-CoV-2 EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV204215_1AQAV204215_1BQAV204215_1CQAV204215_1D
Total Number of Challenges1111
Number of Panel Members5555
Distribution / Testing PeriodQ1Q2Q3Q4
Click to view / hide
Sexually Transmitted Infections

Chlamydia trachomatis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB004101_1QAB004101_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174191_1QAB174191_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Herpes simplex virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994105_1QAV994105_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Human Papillomavirus (Preservcyt) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV094130_1QAV094130_2
Total Number of Challenges12
Number of Panel Members126
Distribution / Testing PeriodQ4Q2 & Q4

Human Papillomavirus (Surepath) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184204_1
Total Number of Challenges1
Number of Panel Members12
Distribution / Testing PeriodQ4

Mycoplasma genitalium EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB184205_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB034126_1QAB034126_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Sexually Transmitted Infections I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154177_1QAB154177_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Sexually Transmitted Infections II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174201_1QAM174201_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Syphilis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154180_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Trichomonas vaginalis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP184202_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3
Click to view / hide
Transplant Associated Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Cytomegalovirus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124150_1QAV124150_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024121_1QAV024121_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134161_1QAV134161_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Cytomegalovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV014120_1QAV014120_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Herpes Virus 6 DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084119_1QAV084119_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Torque Teno Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184203_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Typing

Bacterial 16S EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164183_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Enterovirus Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164185_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

Hepatitis B virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064118_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis C virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034117_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Influenza Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064138_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

MALDI-TOF EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124155_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB074128_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Staphylococcus aureus spa EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134164_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4
Click to view / hide
EQA Pilots

Human Immunodeficiency Virus Type 2 EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204212_1QAV204212_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

Viral Metagenomics NGS EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204213_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ4

Plasmodium spp. (Malaria) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214218_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Francisella tularensis EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAB214220_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

HIV Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214221_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis B Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214223_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis C Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214222_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Unit 5, Technology Terrace, Todd Campus, West of Scotland Science Park Glasgow G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax: +44 (0)141 945 5795 Enquiry Form